Combination of Vaccine With IL-12-Armed Oncolytic Virus SKV-012 Synergistically Potentiates Immune Responses in HPV-Associated Malignancies. [PDF]
Yang N +16 more
europepmc +1 more source
Oncolytic Virus Therapies in Malignant Gliomas: Advances and Clinical Trials. [PDF]
Yang R +4 more
europepmc +1 more source
Oncolytic Virus VV-GMCSF-Lact and Human GM-CSF Against GL261 Glioma in Immunocompetent Mice. [PDF]
Ageenko AB +12 more
europepmc +1 more source
SMAC mimetics sensitize HIV-infected cells to oncolytic virus-mediated death. [PDF]
Molyer B, Ameeriar Y, Angel JB.
europepmc +1 more source
Oncolytic virus therapy in the elderly: immune frailty, challenges, and perspectives. [PDF]
Wang JW +4 more
europepmc +1 more source
Efficacy of Oncolytic Virus VV-GMCSF-Lact Against Immunocompetent Glioma. [PDF]
Ageenko A +10 more
europepmc +1 more source
Cancer genetics and response to oncolytic virus treatment for ovarian cancer. [PDF]
Fletcher EL, Cudmore AO, Vanderhyden BC.
europepmc +1 more source
Oncolytic virus therapy for hepatocellular carcinoma: A bibliometric analysis of research landscapes, hotspots, and clinical transformation trends from 2000 to mid-2025. [PDF]
Yu F, Yin S, Zhu J, Sun K.
europepmc +1 more source
Mechanisms of Oncolytic Virus-Induced Multi-Modal Cell Death and Therapeutic Prospects. [PDF]
Xu J, Liu C, An Y, Sun J, Wang S, Xia Q.
europepmc +1 more source

